US Stock MarketDetailed Quotes

TARA Protara Therapeutics

Watchlist
  • 2.340
  • +0.030+1.30%
Close Jul 11 16:00 ET
  • 2.440
  • +0.100+4.27%
Post 19:11 ET
48.18MMarket Cap-625P/E (TTM)

About Protara Therapeutics Company

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Company Profile

SymbolTARA
Company NameProtara Therapeutics
Listing DateOct 22, 2014
Issue Price10.00
Founded2006
CEOMr. Jesse Shefferman, PhD
MarketNASDAQ
Employees27
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address345 Park Avenue South,3rd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-646-844-0337
Websitehttp://www.protaratx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jesse Shefferman, PhD
  • Chief Executive Officer, President and Director
  • 1.91M
  • Jacqueline Zummo, M.B.A.,M.P.H.,PhD
  • Senior Vice President and Chief Scientific Operations Officer
  • 1.04M
  • Patrick Fabbio
  • Chief Financial Officer
  • 1.44M
  • Luke M. Beshar
  • Chairman of the Board
  • 192.26K
  • Dr. Roger J. Garceau,M.D.,F.A.A.P.
  • Independent Director
  • 91.76K
  • Dr. Jane Huang, M.D.
  • Independent Director
  • 85.76K
  • Barry P. Flannelly, Pharm.D.
  • Independent Director
  • 66.76K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 118.26K
  • Dr. Michael Edward Solomon, PhD
  • Independent Director
  • 71.76K
  • Gregory P. Sargen
  • Independent Director
  • 75.76K
  • Cynthia Smith
  • Independent Director
  • 72.76K
  • Hannah Fry
  • Controller
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg